Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers

Neurobiology of Aging

Volumn 36, Issue 5, 2015, Pages 1771-1779

  Gordon, Brian A ^a,b   Zacks, Jeffrey M ^a,c   Blazey, Tyler ^c   Benzinger, Tammie L S ^a,b,c   Morris, John C ^b   Fagan, Anne M ^b   Holtzman, David M ^b,c   Balota, David A ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Alzheimer; Alzheimer's disease; Amyloid; Attention; Biomarkers; Dementia; FMRI; Ptau; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; PITTSBURGH COMPOUND B; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BOLD SIGNAL; CEREBROSPINAL FLUID ANALYSIS; COGNITION ASSESSMENT; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; MALE; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; STROOP TEST; TASK PERFORMANCE; AGED; BRAIN; CEREBROSPINAL FLUID; COGNITION; DISEASE COURSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATTENTION; BIOMARKERS; BRAIN; COGNITION; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84933182512     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.01.019     Document Type: Article

References (63)

1. Aizenstein H.J., Nebes R.D., Saxton J.a, Price J.C., Mathis C.a, Tsopelas N.D., Ziolko S.K., James J.A., Snitz B.E., Houck P.R., Bi W., Cohen A.D., Lopresti B.J., DeKosky S.T., Halligan E.M., Klunk W.E. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 2008, 65:1509-1517.
2. Albert M.S., Moss M.B., Tanzi R.E., Jones K. Preclinical prediction of AD using neuropsychological tests. J.Int. Neuropsychol. Soc. 2001, 7:631-639.
3. Aschenbrenner A.J., Balota D.A., Tse C.-S., Fagan A.M., Holtzman D.M., Benzinger T.L.S., Morris J.C. Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults. Neuropsychology 2014, http://dx.doi.org/10.1037/neu0000133.
4. Bäckman L., Jones S., Berger A.-K., Laukka E.J., Small B.J. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005, 19:520-531.
5. Balota D.A., Ducheck J.M. Attention variability, and biomarkers in Alzheimer's disease. Remembering: Attributions, Processes, and Control in Human Memory 2014, 285-303. Psychology Press, New York, NY. D. Lindsay, C. Kelley, A.P. Yonelinas, H.L.,. Roediger (Eds.).
6. Balota D.A., Faust M.E. Attention in dementia of the Alzheimer's type. Handbook of Neuropsychology 2001, 51-80. Elsevier Science, New York, NY. F. Boller, S. Cappa (Eds.).
7. Balota D.A., Tse C.-S., Hutchison K.A., Spieler D.H., Duchek J.M., Morris J.C. Predicting conversion to dementia of the Alzheimer's type in a healthy control sample: the power of errors in Stroop color naming. Psychol. Aging 2010, 25:208-218.
8. Banich M.T., Milham M.P., Atchley R., Cohen N.J., Webb A., Wszalek T., Kramer A.F., Liang Z.-P., Wright A., Shenker J., Magin R. fMRI studies of Stroop tasks reveal unique roles of anterior and posterior brain systems in attentional selection. J.Cogn. Neurosci. 2000, 12:988-1000.
9. Bateman R.J., Xiong C., Benzinger T.L.S., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., Holtzman D.M., Santacruz A., Buckles V., Oliver A., Moulder K., Aisen P.S., Ghetti B., Klunk W.E., McDade E., Martins R.N., Masters C.L., Mayeux R., Ringman J.M., Rossor M.N., Schofield P.R., Sperling R.A., Salloway S., Morris J.C. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N.Engl. J. Med. 2012, 367:795-804.
10. Benzinger T.L.S., Blazey T., Jack C.R., Koeppe R.A., Su Y., Xiong C., Raichle M.E., Snyder A.Z., Ances B.M., Bateman R.J., Cairns N.J., Fagan A.M., Goate A., Marcus D.S., Aisen P.S., Christensen J.J., Ercole L., Hornbeck R.C., Farrar A.M., Aldea P., Jasielec M.S., Owen C.J., Xie X., Mayeux R., Brickman A., McDade E., Klunk W., Mathis C.A., Ringman J., Thompson P.M., Ghetti B., Saykin A.J., Sperling R.A., Johnson K.A., Salloway S., Correia S., Schofield P.R., Masters C.L., Rowe C., Villemagne V.L., Martins R., Ourselin S., Rossor M.N., Fox N.C., Cash D.M., Weiner M.W., Holtzman D.M., Buckles V.D., Moulder K., Morris J.C. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E4502-E4509.
11. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst. Rev. 2006, 1:CD005593.
12. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64:501-508.
13. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Sanders A., Pericak-Vance M.A., Mazziotta J.C., Small G.W., Saunders A.M. Patterns of brain activations in people at risk for Alzheimer's disease. N.Engl. J. Med. 2000, 343:450-456.
14. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991, 239-259.
15. Corbetta M., Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nat. Rev. Neurosci. 2002, 3:201-215.
16. Coull J.T., Nobre A.C. Where and when to pay attention: the neural systems for directing attention to spatial locations and to time intervals as revealed by both PET and fMRI. J.Neurosci. 1998, 18:7426-7435.
17. Craik F.I.M., Lockhart R.S. Levels of processing: a framework for memory research. J.Verbal Learn. Verbal Behav. 1972, 11:671-684.
18. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.a, Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement. 2010, 6:303-311.
19. Derrfuss J., Brass M., Neumann J., von Cramon D.Y. Involvement of the inferior frontal junction in cognitive control: meta-analyses of switching and Stroop studies. Hum. Brain Mapp. 2005, 25:22-34.
20. Duchek J.M., Balota D.a, Thomas J.B., Snyder A.Z., Rich P., Benzinger T.L., Fagan A.M., Holtzman D.M., Morris J.C., Ances B.M. Relationship between Stroop performance and resting state functional connectivity in cognitively normal older adults. Neuropsychology 2013, 27:516-528.
21. Fagan A.M., Mintun M.A., Mach R.H., Lee S.-Y., Dence C.S., Shah A.R., LaRossa G.N., Spinner M.L., Klunk W.E., Mathis C.A., DeKosky S.T., Morris J.C., Holtzman D.M. Inverse relation between invivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans. Ann. Neurol. 2006, 59:512-519.
22. Faust M.E., Ferraro F.R., Balota D.A., Spieler D.H. Individual differences in information-processing rate and amount: implications for group differences in response latency. Psychol. Bull. 1999, 125:777-799.
23. Filbey F.M., Chen G., Sunderland T., Cohen R.M. Failing compensatory mechanisms during working memory in older apolipoprotein E-epsilon4 healthy adults. Brain Imaging Behav. 2010, 4:177-188.
24. Fischl B. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
25. Gomez-Isla T., Price J.L., Mckeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J.Neurosci. 1996, 16:4491-4500.
26. Grossman M., Koenig P., DeVita C., Glosser G., Alsop D., Detre J., Gee J. The neural basis for category-specific knowledge: an fMRI study. Neuroimage 2002, 15:936-948.
27. Han S.D., Houston W.S., Jak A.J., Eyler L.T., Nagel B.J., Fleisher A.S., Brown G.G., Corey-Bloom J., Salmon D.P., Thal L.J., Bondi M.W. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol. Aging 2007, 28:238-247.
28. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
29. Himmelheber A.M., Sarter M., Bruno J.P. Increases in cortical acetylcholine release during sustained attention performance in rats. Cogn. Brain Res. 2000, 9:313-325.
30. Holtzman D., Morris J.C., Goate A.M. Alzheimer's disease: the challenge of the second century. Sci. Transl. Med. 2011, 3:1-17.
31. Hutchison K.A., Balota D.A., Duchek J.M., Ducheck J.M. The utility of Stroop task switching as a marker for early-stage Alzheimer's disease. Psychol. Aging 2010, 25:545-559.
32. Ingelsson M., Fukumoto H., Newell K.L., Growdon J.H., Hedley-Whyte E.T., Frosch M.P., Albert M.S., Hyman B.T., Irizarry M.C. Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004, 62:925-931.
33. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
34. Jacoby L.L. Aprocess dissociation framework: separating automatic from intentional uses of memory. J.Mem. Lang. 1991, 30:513-541.
35. Jenkinson M., Beckmann C.F., Behrens T.E.J., Woolrich M.W., Smith S.M. FSL. Neuroimage 2012, 62:782-790.
36. Kaduszkiewicz H., Zimmermann T., Beck-Bornholdt H.-P., van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005, 331:321-327.
37. Kane M.J., Engle R.W. The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon. Bull. Rev. 2002, 9:637-671.
38. Kim H. Neural activity that predicts subsequent memory and forgetting: a meta-analysis of 74 fMRI studies. Neuroimage 2011, 54:2446-2461.
39. Kronbichler M., Hutzler F., Wimmer H., Mair A., Staffen W., Ladurner G. The visual word form area and the frequency with which words are encountered: evidence from a parametric fMRI study. Neuroimage 2004, 21:946-953.
40. Lind J., Persson J., Ingvar M., Larsson A., Cruts M., Van Broeckhoven C., Adolfsson R., Bäckman L., Nilsson L.-G., Petersson K.M., Nyberg L. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 2006, 129:1240-1248.
41. MacDonald A.W., Cohen J.D., Stenger A., Carter C.S. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000, 288:1835-1838.
42. Milham M.P., Erickson K.I., Banich M.T., Kramer A.F., Webb A., Wszalek T., Cohen N.J. Attentional control in the aging brain: insights from an fMRI study of the Stroop task. Brain Cogn. 2002, 49:277-296.
43. Mormino E.C., Brandel M.G., Madison C.M., Marks S., Baker S.L., Jagust W.J. Aβ deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb. Cortex 2012, 22:1813-1823.
44. Morris J., Price J.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's Disease. J.Mol. Neurosci. 2001, 17:101-118.
45. Morris J.C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
46. Paller K.A., Wagner A.D. Observing the transformation of experience into memory. Trends Cogn. Sci. 2002, 6:93-102.
47. Pardo J.V., Fox P.T., Raichle M.E. Localization of a human system for sustained attention by positron emission tomography. Nature 1991, 349:61-64.
48. Perry R.J., Hodges J.R. Attention and executive deficits in Alzheimer's disease. A critical review. Brain 1999, 122:383-404.
49. Persson J., Lind J., Larsson A., Ingvar M., Sleegers K., Van Broeckhoven C., Adolfsson R., Nilsson L.-G., Nyberg L. Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia 2008, 46:1679-1687.
50. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B.S., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., DeKosky S.T., Caselli R.J. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6820-6825.
51. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry 1989, 154:797-800.
52. Sarazin M., Berr C., De Rotrou J., Fabrigoule C., Pasquier F., Legrain S., Michel B., Puel M., Volteau M., Touchon J., Verny M., Dubois B. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007, 69:1859-1867.
53. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 1997, 23:28-46.
54. Schneider-Garces N.J., Gordon B.a, Brumback-Peltz C.R., Shin E., Lee Y., Sutton B.P., Maclin E.L., Gratton G., Fabiani M. Span, CRUNCH, and beyond: working memory capacity and the aging brain. J.Cogn. Neurosci. 2010, 22:655-669.
55. Selden N.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998, 121(Pt 1):2249-2257.
56. Storandt M., Head D., Fagan A.M., Holtzman D.M., Morris J.C. Toward a multifactorial model of Alzheimer disease. Neurobiol. Aging 2012, 33:2262-2271.
57. Stroop J.R. Studies of interference in serial verbal reactions. J.Exp. Psychol. 1935, 18:643-662.
58. Su Y., D'Angelo G.M., Vlassenko A.G., Zhou G., Snyder A.Z., Marcus D.S., Blazey T.M., Christensen J.J., Vora S., Morris J.C., Mintun M.A., Benzinger T.L.S. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS One 2013, 8:e73377.
59. Trivedi M.A., Schmitz T.W., Ries M.L., Torgerson B.M., Sager M.A., Hermann B.P., Asthana S., Johnson S.C. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med. 2006, 4:1.
60. Vos S.J., Xiong C., Visser P.J., Jasielec M.S., Hassenstab J., Grant E.A., Cairns N.J., Morris J.C., Holtzman D.M., Fagan A.M. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013, 12:957-965.
61. Wager T.D., Jonides J., Reading S. Neuroimaging studies of shifting attention: a meta-analysis. Neuroimage 2004, 22:1679-1693.
62. Woolrich M.W., Behrens T.E.J., Beckmann C.F., Jenkinson M., Smith S.M. Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 2004, 21:1732-1747.
63. Worsley K.J., Evans A.C., Marrett S., Neelin P. Athree-dimensional statistical analysis for CBF activation studies in human brain. J.Cereb. Blood Flow Metab. 1992, 12:900-918.